These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9627709)

  • 21. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
    Rutberg SE; Adams TL; Glick A; Bonovich MT; Vinson C; Yuspa SH
    Cancer Res; 2000 Nov; 60(22):6332-8. PubMed ID: 11103794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of interfollicular and hair follicle derived cells as targets for the v-rasHa oncogene in mouse skin carcinogenesis.
    Weinberg WC; Morgan DL; George C; Yuspa SH
    Carcinogenesis; 1991 Jun; 12(6):1119-24. PubMed ID: 2044193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of phospholipid metabolism in murine keratinocytes transformed by the v-ras oncogene: relationship of phosphatidylinositol turnover and cytokine stimulation to the transformed phenotype.
    Lee E; Punnonen K; Cheng C; Glick A; Dlugosz A; Yuspa SH
    Carcinogenesis; 1992 Dec; 13(12):2367-73. PubMed ID: 1473246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression.
    Tennenbaum T; Yuspa SH; Grover A; Castronovo V; Sobel ME; Yamada Y; De Luca LM
    Cancer Res; 1992 May; 52(10):2966-76. PubMed ID: 1533815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
    Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH
    Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis.
    Shukla A; Ho Y; Liu X; Ryscavage A; Glick AB
    Mol Cancer Res; 2008 Mar; 6(3):509-16. PubMed ID: 18337457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
    Go C; Li P; Wang XJ
    Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in murine keratinocyte differentiation induced by activated rasHa genes are mediated by protein kinase C-alpha.
    Dlugosz AA; Cheng C; Williams EK; Dharia AG; Denning MF; Yuspa SH
    Cancer Res; 1994 Dec; 54(24):6413-20. PubMed ID: 7987836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
    Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
    J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas.
    Wang XJ; Greenhalgh DA; Lu XR; Bickenbach JR; Roop DR
    Oncogene; 1995 Jan; 10(2):279-89. PubMed ID: 7530825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
    Weinberg WC; Montano NE; Deng C
    Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis.
    Gold LI; Jussila T; Fusenig NE; Stenbäck F
    J Pathol; 2000 Apr; 190(5):579-88. PubMed ID: 10727984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-beta.
    Matsumoto K; Hashimoto K; Hashiro M; Yoshimasa H; Yoshikawa K
    J Cell Physiol; 1990 Oct; 145(1):95-101. PubMed ID: 2211846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of transforming growth factor-beta 1 expression in benign skin tumors of p53null mice is prognostic for a high risk of malignant conversion.
    Cui W; Kemp CJ; Duffie E; Balmain A; Akhurst RJ
    Cancer Res; 1994 Nov; 54(22):5831-6. PubMed ID: 7954410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin.
    Piazza GA; Ritter JL; Baracka CA
    Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.
    Wilkins-Port CE; Higgins PJ
    Cells Tissues Organs; 2007; 185(1-3):116-22. PubMed ID: 17587817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
    Santibáñez JF; Frontelo P; Iglesias M; Martínez J; Quintanilla M
    J Cell Biochem; 1999 Jul; 74(1):61-73. PubMed ID: 10381262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A; Tredget EE; Shen Q
    J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.